Finance

Lists
Why is TNXP down ९.०४%?
Dive Deeper
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$ ६.६४
-९.०४%
(-०.६६) 1D
US$ ६.५५
-१.३६% (-०.०९०)
Pre-market
Closed: अक्टोबर १२, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNXP...
Open
US$ ७.२४
High
US$ ७.२८
Low
US$ ६.६४
Mkt. cap
११.३९ करोड
Avg. vol.
५.९५ लाख
Volume
४.३५ हजार
52-wk high
US$ २०.६९
52-wk low
US$ ६.६४
EPS
-US$ १२.९२
Beta
१.७८
Shares outstanding
१.७२ करोड
No. of employees
१४२
Open
US$ ७.२४
High
US$ ७.२८
Low
US$ ६.६४
Mkt. cap
११.३९ करोड
Avg. vol.
५.९५ लाख
Volume
४.३५ हजार
52-wk high
US$ २०.६९
52-wk low
US$ ६.६४
EPS
-US$ १२.९२
Beta
१.७८
Shares outstanding
१.७२ करोड
No. of employees
१४२
News stories
From web sources and news partners
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees१४२
Founded२००७
HeadquartersBerkeley Heights, न्यु जर्सी, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to TNXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TNXP in the last 3 months.
Highest
Current US$ ६.६४
US$ ६५.०० (+८७८.९२%)
Average
US$ ३८.०० (+४७२.२९%)
Lowest
US$ २२.०० (+२३१.३३%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Reiterated
US$ ६५.००
+८७८.९%
09/28/2026
Stacy Ku
TD Cowen
Buy
Maintained
US$ २२.००
+२३१.३%
08/10/2026
Tiago Fauth
Raymond James
Buy
Reiterated
US$ २७.००
+३०६.६%
08/10/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$ ३७.००
+४५७.२%
03/16/2026
Last report
२०२६ अगस्ट १०
Fiscal period
Q2 2026
-US$ २.४७ / -US$ २.६२
+५.५८%beat
Revenue / Est. (USD)
१.३५ करोड / ७७.२२ लाख
+७५.३८%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३२.९० लाख
५३.९० लाख
६८.७८ लाख
१.३५ करोड
Cost of goods sold
१३.६७ लाख
१०.५८ लाख
१५.७८ लाख
७.०३ लाख
Cost of revenue
१३.६७ लाख
१०.५८ लाख
१५.७८ लाख
७.०३ लाख
Research and development expenses
९२.८९ लाख
१.६९ करोड
१.८२ करोड
१.९४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.५७ करोड
३.५७ करोड
२.८६ करोड
३.६० करोड
Operating expense
३.५० करोड
५.२६ करोड
४.६८ करोड
५.५४ करोड
Total operating expenses
३.६४ करोड
५.३७ करोड
४.८४ करोड
५.६१ करोड
Operating income
-३.३१ करोड
-४.८३ करोड
-४.१५ करोड
-४.२५ करोड
Other non operating income
-१.७४ लाख
३२.०० हजार
-३.०० हजार
५.५१ लाख
EBT including unusual items
-३.२० करोड
-४.६९ करोड
-४.०२ करोड
-४.०६ करोड
EBT excluding unusual items
-३.२० करोड
-४.६९ करोड
-४.०२ करोड
-४.०६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३.२० करोड
-४.६९ करोड
-४.०२ करोड
-४.०६ करोड
Net profit margin
-९७२.९५%
-८७०.३२%
-५८४.३८%
-२९९.४१%
Earnings per share
-३.७०
-३.९८
-२.९३
-२.४७
Interest and investment income
१२.३१ लाख
१३.४४ लाख
१३.४६ लाख
१४.३२ लाख
Interest expense
-
-
-
-
Net interest expenses
१२.३१ लाख
१३.४४ लाख
१३.४६ लाख
१४.३२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.२६ करोड
-४.७८ करोड
-४.१० करोड
-४.१९ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू